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Abstrg:t FR 900506 (PH) is a new imnmn~ve ckug which prd<qS 
allqtl'8ft SJl'Viwl. 0Jr sIudies have caqJB1'ed the in yi1ro inhibitcry 
effects of FR and Cyclosporine (OIA) on human lymphocyte 
proliferation. Chnsiderably lower dc&!s of FR were l'eCJ.Iired to 
~ inhibition of lymphooyte prdibation in<b!ed by C<lIDUI8wlin 
A (ChnA) stimulation 01" in primary mixed lymphooyte ftlICtims 
(MLR). Similar diflftlllooS between FR and CkA were dJserwm with 
the seeonduy stiIwlation of allosetha1ed T cells gmera1ed in MLR 
01" propagated from Iiwr tran1tlIant biqJSies. Thege dlservatims 
provide ftJrther evi~ that FR is mrut 500 fd.d IIlO'e po1I!Ilt than 
OIA and may be a useful immunosuppressive agent in organ 
tran1tlIan1ation. 
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The new irrununosuppressive drug, FR 900506, (FR) 
greatly prolongs heart, kidney, and liver allograft 
sur v i val in rat s 0 r dog s (1- 3) • In vitrQ FR i nh i bit s 
the murine mixed leukocyte reaction (MLR) and the 
generation of human cytotoxic cells (1). Its 
irrununosuppressive effect seems to be mediated through 
inhibition of Interleukin-2 (IL-2) release and there is 
also a diminished appearance of IL-2 receptors on 
activated lymphocytes (1). We describe here a 
c omp a r i son 0 f the .in vitro i rrunu nos u p pre s s i vee f f e c t s 0 f 
FR and Cyclosporine (CsA) on human lymphocytes. 
MAqbfrAi~_Am;iMb:rulaR 
~n~An!!v!!lia_iiK!~aAKl_gmg:uKc~iiAKcK1jvglK1jaa 
Human peripheral blood lymphocytes (PBL) were isolated 
from heparinized blood by Ficoll-Hypaque density 
gradient centrifugation. Using 96-well round-bottom 
microplates, these cells (10 5/well) were incubated at 
37 0 C in 200 ul of tissue culture medium (TCM) 
suplemented wi th 10% human serum in the presence of 
Con-A (10 ug/ml) for 72 hours. During the final 20 
hours of incubation, each culture was labeled with one· 
uCi of 3H-thymidine. The cultures were harvested and 
counted in liquid scintillation counter as previously 
described (4). 
Unidirectional human MLR cultures were set up with 10 5 
responder and 10 5 irradiated (2000 R) stimulator cells 
in a volume of 200 ul TCM supplemented with 10% human 
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serum for 6 days. Prol iferation was assessed by the 
degree of 3H-thymidine incorporation during the final 
20 hours of incubation (4). 
Alloreactive human T cell clones were generated from m 
l11m MLR cultures as previously described (4). 
All oreac ti ve I ymphocyte cuI tures were al so propaga ted 
from human liver core biopsies in the presence of 
interleukin 2 (IL-2) (2). Secondary proliferation of 
alloreactive cells was assessed in a three-day primed 
lymphocyte test (PLT), whereby 10 4 responder cells were 
incubated with 10 5 irradiated (2000 R) stimulator cells 
(4). Lymphocyte proliferation was assessed by 3H_ 
thymidine incorporation as described above. 
FR was kindly suppl ied by the Fuj isawa Corporation, 
Osaka, Japan as a crystalline powder. It was dissolved 
in methanol and kept in -40 C. CsA was obtained from 
Sandoz. It was dissolved in ethanol and kept at -40 C. 
ag4~_Bll~~ls_g1_bB_aa~_~s~ga 
iglaahg~gl~_f~gljl§~Aljga 
The immunosuppressive effect of FR and CsA on the Con-
A-induced response, MLR reactivity and PLT response of 
alloreactive lymphocytes was measured at different 
concentrations of drugs ranging from 0.06 - 500 ng/ml. 
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The results were expressed as percent inhibition using 
the formula: 
% inhibition = (1- __ :~i~l_~~~~_~~~~ __ ) x100 
cpm wi thout drug 
Studies on Con-A-induced prol i ferat ion showed that FR 
had a much higher inhibitory effect than CsA. This is 
illustrated in Figure 1, which shows that significant 
inhibition was observed at concentrations of FR that 
were 500 to 1000 fold lower than those of CsA. 
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FIGURE 1 Inhibition of ConA induced proliferation of 
lymphocytes by FR and CsA. 
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Similar differences were observed in the dose 
effects of FR and CsA-induced inhibition of the primary 
MLR (Figure 2). 
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FIGURE 2 Dose ef fect s of FR and CsA on MLR induced 
lymphocyte proliferation. 
Kinetic studies of MLR inhibition by FR showed 
that the strongest effect was observed when FR was 
added during the first day of culture (Table 1). 
320 
TABLE I 
FR ug/ml 
.5 
.05 
.005 
A. ZEEVI et al. 
Inhibition of MLR response by FR added 
at various times during culture 
% Inhibition of MLR Response (FR 
added on) 
Day 1 Day 2 Day 3 Day 4 
84 55 30 24 
68 48 27 o 
65 37 20 o 
The inhibitory effects of FR and esA were also 
determined in secondary proliferation assays with 
a 11 0 act i vat edT cell s • Fig u r e 3 de pic t s the fin ding s 
with an MLR-generated alloreactive T cell clone DB29 
which was specific for a DQwl-associated cellular 
determinant on class II molecules encoded by the HLA-DQ 
subregion (6). 
% 
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FIGURE 3 Immunosuppressive effect of FR and esA on the 
PLT reactivity of alloreactive T cell clone 
DB29. 
It may be seen that significant inhibition of the 
PLT response of DB29 occurred at about 300-fold lower 
concentrations of FR than of esA. Similar differences 
between FR and esA were observed with the donor-
specific PLT response of alloactivated T cells 
propagated from a liver transplant biopsy (Figure 4). 
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FIGURE 4 Inhibition of donor specific PLT response of 
alloreactive T cells propagated from a liver 
transplant biopsy. 
These results extend the original observations by 
Oc h i a i eta 1. ( 1), t hat FR has a pot en t in Yit.l:Q 
suppressive effect on human lymphocyte activation. 
This was observed not only in primary activation of 
1 ymphocy tes induced by Con-A or in MLR bu t al so in 
secondary stimulation of alloactivated T cells 
g e n era ted i n MLR 0 r pro p a gat e d from 1 i ve r t ran s pIa n t 
biopsies. Thus, FR not only suppresses T lymphocyte 
alloactivation but also inhibits the alloantigen 
induced expansion of activated T cells including cells 
which may be found in cellular infiltrates of organ 
t ran s pIa n t s • On the 0 the r han d, FR has n 0 e f f e c ton 
the IL2-induced proliferation of alloactivated T cells 
IN VITRO EFFECTS OF FR 900506 
( 5 ) • Th i sis c omp a t i b lew i t h the 
mechanism of the immunosuppressive 
mediated through an inhibition of 
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concept 
effect 
that 
of FR 
IL2 release 
the 
is 
( 1) • 
Indeed, 
suggest 
preliminary studies in 
that FR blocks IL2 
our laboratory also 
release (unpublished 
observations). 
that of CyA. 
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